|
1
|
Huang L, Yang Y, Yang F, Liu S, Zhu Z, Lei
Z and Guo J: Functions of EpCAM in physiological processes and
diseases (Review). Int J Mol Med. 42:1771–1785. 2018.PubMed/NCBI
|
|
2
|
Lei Z, Maeda T, Tamura A, Nakamura T,
Yamazaki Y, Shiratori H, Yashiro K, Tsukita S and Hamada H: EpCAM
contributes to formation of functional tight junction in the
intestinal epithelium by recruiting claudin proteins. Dev Biol.
371:136–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guerra E, Lattanzio R, La Sorda R, Dini F,
Tiboni GM, Piantelli M and Alberti S: mTrop1/Epcam knockout mice
develop congenital tufting enteropathy through dysregulation of
intestinal E-cadherin/β-catenin. PLoS One. 7:pp. e493022012,
View Article : Google Scholar
|
|
4
|
Mueller JL, McGeough MD, Peña CA and
Sivagnanam M: Functional consequences of EpCam mutation in mice and
men. Am J Physiol Gastrointest Liver Physiol. 306:G278–G288. 2014.
View Article : Google Scholar :
|
|
5
|
Yousaf M, Tayyeb A and Ali G: Expression
profiling of adhesion proteins during prenatal and postnatal liver
development in rats. Stem Cells Cloning. 10:21–28. 2017.PubMed/NCBI
|
|
6
|
Tanaka M, Okabe M, Suzuki K, Kamiya Y,
Tsukahara Y, Saito S and Miyajima A: Mouse hepatoblasts at distinct
developmental stages are characterized by expression of EpCAM and
DLK1: Drastic change of EpCAM expression during liver development.
Mech Dev. 126:665–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okabe M, Tsukahara Y, Tanaka M, Suzuki K,
Saito S, Kamiya Y, Tsujimura T, Nakamura K and Miyajima A:
Potential hepatic stem cells reside in EpCAM+ cells of normal and
injured mouse liver. Development. 136:1951–1960. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmelzer E, Zhang L, Bruce A, Wauthier E,
Ludlow J, Yao HL, Moss N, Melhem A, McClelland R, Turner W, et al:
Human hepatic stem cells from fetal and postnatal donors. J Exp
Med. 204:1973–1987. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu H, Ma J, Yang Y, Shi W and Luo L: EpCAM
is an endoderm-specific Wnt derepressor that licenses hepatic
development. Dev Cell. 24:543–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsumoto T, Takai A, Eso Y, Kinoshita K,
Manabe T, Seno H, Chiba T and Marusawa H: Proliferating
EpCAM-positive ductal cells in the inflamed liver give rise to
hepatocellular carcinoma. Cancer Res. 77:6131–6143. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamashita T, Forgues M, Wang W, Kim JW, Ye
Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, et al: EpCAM and
alpha-fetoprotein expression defines novel prognostic subtypes of
hepatocellular carcinoma. Cancer Res. 68:1451–1461. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamashita T, Ji J, Budhu A, Forgues M,
Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, et al:
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating
cells with stem/progenitor cell features. Gastroenterology.
136:1012–1024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji J, Yamashita T, Budhu A, Forgues M, Jia
HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, et al: Identification
of microRNA-181 by genome-wide screening as a critical player in
EpCAM-positive hepatic cancer stem cells. Hepatology. 50:472–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mani SK, Zhang H, Diab A, Pascuzzi PE,
Lefrançois L, Fares N, Bancel B, Merle P and Andrisani O:
EpCAM-regulated intra-membrane proteolysis induces a cancer stem
cell-like gene signature in hepatitis B virus-infected hepatocytes.
J Hepatol. 65:888–898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song Y, Liu C, Liu X, Trottier J, Beaudoin
M, Zhang L, Pope C, Peng G, Barbier O, Zhong X, et al: H19 promotes
cholestatic liver fibrosis by preventing ZEB1-mediated inhibition
of epithelial cell adhesion molecule. Hepatology. 66:1183–1196.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu C, Sun X, Li N, Wang W, Kuang D, Tong
P, Han Y and Dai J: CircRNAs in the tree shrew (Tupaia belangeri)
brain during postnatal development and aging. Aging (Albany NY).
10:833–852. 2018. View Article : Google Scholar
|
|
17
|
Maiese K: Disease onset and aging in the
world of circular RNAs. J Transl Sci. 2:327–329. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo Q, Zhang L, Li X, Fu B, Deng Z, Qing
C, Su R, Xu J, Guo Y, Huang Z and Li J: Identification of circular
RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for
rheumatoid arthritis. Clin Exp Immunol. 194:118–124. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X and Fang L: Advances in circular
RNAs and their roles in breast cancer. J Exp Clin Cancer Re.
37:2062018. View Article : Google Scholar
|
|
20
|
Holdt LM, Kohlmaier A and Teupser D:
Molecular functions and specific roles of circRNAs in the
cardiovascular system. Noncoding RNA Res. 3:75–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu CX and Sun S: An emerging role for
circular RNAs in osteoarthritis. Yonsei Med J. 59:349–355. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao R, Zou H and Liao W: Prospect of
circular RNA in hepatocellular carcinoma: A novel potential
biomarker and therapeutic target. Front Oncol. 8:3322018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo XY, He CX, Wang YQ, Sun C, Li GM, Su
Q, Pan Q and Fan JG: Circular RNA profiling and bioinformatic
modeling identify its regulatory role in hepatic steatosis. Biomed
Res Int. 2017:59361712017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo J, Zhou Y, Cheng Y, Fang W, Hu G, Wei
J, Lin Y, Man Y, Guo L, Sun M, et al: Metformin-induced changes of
the coding transcriptome and non-coding RNAs in the livers of
non-alcoholic fatty liver disease mice. Cell Physiol Biochem.
45:1487–1505. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Langmead B and Salzberg SL: Fast
gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: Accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi E, Zhang X, Xing C and Yu H: Mitotic
checkpoint regulators control insulin signaling and metabolic
homeostasis. Cell. 166:567–581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stygar D, Andrare D, Bażanów B, Chełmecka
E, Sawczyn T, Skrzep-Poloczek B, Olszańska E, Karcz KW and Jochem
J: The impact of DJOS surgery, a high fat diet and a control diet
on the enzymes of glucose metabolism in the liver and muscles of
Sprague-Dawley rats. Front Physiol. 10:5712019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adeva-Andany MM, González-Lucán M,
Donapetry-García C, Fernández-Fernández C and Ameneiros-Rodríguez
E: Glycogen metabolism in humans. BBA Clin. 5:85–100. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang DD, Zhang JG, Wang YZ, Liu Y, Liu GL
and Li XY: Per-Arnt-Sim Kinase (PASK): An emerging regulator of
mammalian glucose and lipid metabolism. Nutrients. 7:7437–7450.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hajiaghaalipour F, Khalilpourfarshbafi M
and Arya A: Modulation of glucose transporter protein by dietary
flavonoids in type 2 diabetes mellitus. Int J Biol Sci. 11:508–524.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Terris B, Cavard C and Perret C: EpCAM, a
new marker for cancer stem cells in hepatocellular carcinoma. J
Hepatol. 52:280–281. 2010. View Article : Google Scholar
|
|
34
|
Weiss TS and Dayoub R: Thy-1
(CD90)-positive hepatic progenitor cells, hepatoctyes, and
non-parenchymal liver cells isolated from human livers. Methods Mol
Biol. 1506:75–89. 2017. View Article : Google Scholar
|
|
35
|
Bose R and Ain R: Regulation of
transcription by circular RNAs. Adv Exp Med Biol. 1087:81–94. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Franz A, Rabien A, Stephan C, Ralla B,
Fuchs S, Jung K and Fendler A: Circular RNAs: A new class of
biomarkers as a rising interest in laboratory medicine. Clin Chem
Lab Med. 56:1992–2003. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Q, Yang ZL, Zou Q, Yuan Y, Li J,
Liang L, Zeng G and Chen S: SHP2 and UGP2 are biomarkers for
progression and poor prognosis of gallbladder cancer. Cancer
Invest. 34:255–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khandelwal P, Sinha A, Jain V, Houghton J,
Hari P and Bagga A: Fanconi syndrome and neonatal diabetes:
Phenotypic heterogeneity in patients with GLUT2 defects. CEN Case
Rep. 7:1–4. 2018. View Article : Google Scholar :
|
